Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1CNS 1

Conditions

Neuroblastoma 51Central Nervous System Neoplasms 43Medulloblastoma 22Brain Neoplasms 20Astrocytoma 15Oligodendroglioma 14Rhabdoid Tumor 7Choroid Plexus Neoplasms 7Neoplasms 6Glioma 6Optic Nerve Glioma 5Ganglioneuroblastoma 5Spinal Cord Neoplasms 4Sarcoma 4Neuroectodermal Tumors, Primitive 4Glioblastoma 4Sarcoma, Ewing 3Rhabdomyosarcoma 3Recurrence 3Lymphoma 3Gliosarcoma 3Ependymoma 3Wilms Tumor 2Pinealoma 2Neurofibromatosis 1 2Familial ependymoma 2Untreated Childhood Medulloblastoma 1Retinoblastoma 1Pyloric Stenosis, Hypertrophic 1Ototoxicity 1

Interventions

merphos 1Vincristine 1Methotrexate 1Mental Status and Dementia Tests 1Etoposide 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Basal Cell Nevus Syndrome × Vincristine × CNS × Clear all
NCT02017964 2023-01-09

Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma

Children's Oncology Group

Phase 2 Completed
26 enrolled 14 charts
CNSDermatologic

Basal Cell Nevus Syndrome, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡